Titomic Secures Early Manufacturing Development Contract with Leading Defense Prime
HUNTSVILLE, Ala., Dec. 15, 2025 /PRNewswire/ -- Titomic Limited (ASX: TTT), a…
Milestone Receives FDA Approval of CARDAMYST (etripamil) as First and Only Self-Administered Nasal Spray for Adults with Paroxysmal Supraventricular Tachycardia (PSVT)
First FDA approved treatment in 30+ years for more than 2 million…
Successful Hot Fire Test on a Solid Rocket Motor Thrust Chamber Additively Manufactured by Titomic’s TKF Cold Spray
HUNTSVILLE, Ala., Dec. 3, 2025 /PRNewswire/ -- Titomic Limited (ASX: TTT), a…
SAMURAI Paint Celebrates 28 Years of Excellence with the Launch of Its First-Ever Car Spray Paint Series
KUALA LUMPUR, Malaysia, Nov. 3, 2025 /PRNewswire/ -- SAMURAI Paint, the internationally…
Titomic Appoints Aude Vignelles as President of Asia-Pacific Region
MELBOURNE, Australia, Sept. 26, 2025 /PRNewswire/ -- Titomic Limited (ASX: TTT), a global…
Titomic Celebrates Grand Opening of New European Facility in Heerenveen, Netherlands
HEERENVEEN, Netherlands, Sept. 24, 2025 /PRNewswire/ -- Titomic Limited (ASX: TTT), a global leader…
Titomic – Driving Innovation and Securing the Future in FY2025
HUNTSVILLE, Ala., Aug. 27, 2025 /PRNewswire/ -- Titomic Limited (ASX: TTT), a global…
EURneffy (adrenaline nasal spray) Approved in the U.K. as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis)
EURneffy (neffy® in the U.S.) offers a new delivery method for adrenaline…